Receptor, Cannabinoid, CB2
"Receptor, Cannabinoid, CB2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of cannabinoid receptor found primarily on immune cells where it may play a role modulating release of CYTOKINES.
MeSH Number(s)
D12.776.543.750.100.125.200
Concept/Terms
Receptor, Cannabinoid, CB2- Receptor, Cannabinoid, CB2
- CB2 Receptor
- Receptor, CB2
- Cannabinoid Receptor CB2
- CB2, Cannabinoid Receptor
- Receptor CB2, Cannabinoid
Below are MeSH descriptors whose meaning is more general than "Receptor, Cannabinoid, CB2".
Below are MeSH descriptors whose meaning is more specific than "Receptor, Cannabinoid, CB2".
This graph shows the total number of publications written about "Receptor, Cannabinoid, CB2" by people in Harvard Catalyst Profiles by year, and whether "Receptor, Cannabinoid, CB2" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 2 | 2 |
| 2006 | 1 | 1 | 2 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 2 | 0 | 2 |
| 2010 | 2 | 3 | 5 |
| 2011 | 1 | 1 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 3 | 1 | 4 |
| 2014 | 0 | 1 | 1 |
| 2015 | 3 | 0 | 3 |
| 2016 | 2 | 2 | 4 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 2 | 3 |
| 2019 | 3 | 1 | 4 |
| 2020 | 3 | 0 | 3 |
Below are the most recent publications written about "Receptor, Cannabinoid, CB2" by people in Profiles.
-
Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors. J Med Chem. 2020 09 24; 63(18):10287-10306.
-
Xie2-64, a novel CB2 receptor inverse agonist, reduces cocaine abuse-related behaviors in rodents. Neuropharmacology. 2020 10 01; 176:108241.
-
The Role of the Cannabinoid System in Pain Control: Basic and Clinical Implications. Curr Pain Headache Rep. 2020 Jun 06; 24(7):35.
-
Dipyrone is locally hydrolyzed to 4-methylaminoantipyrine and its antihyperalgesic effect depends on CB2 and kappa-opioid receptors activation. Eur J Pharmacol. 2020 May 05; 874:173005.
-
Structure-Activity Relationship Studies of Pyridine-Based Ligands and Identification of a Fluorinated Derivative for Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors. J Med Chem. 2019 12 26; 62(24):11165-11181.
-
Myocardial maladaptation to pressure overload in CB2 receptor-deficient mice. J Mol Cell Cardiol. 2019 08; 133:86-98.
-
2-Arachidonoylglycerol mobilizes myeloid cells and worsens heart function after acute myocardial infarction. Cardiovasc Res. 2019 03 01; 115(3):602-613.
-
Cannabinoid receptor 2 deficiency exacerbates inflammation and neutrophil recruitment. FASEB J. 2019 05; 33(5):6154-6167.
-
Preclinical evaluation of [18 F]MA3: a CB2 receptor agonist radiotracer for PET. Br J Pharmacol. 2019 05; 176(10):1481-1491.
-
Progress in brain cannabinoid CB2 receptor research: From genes to behavior. Neurosci Biobehav Rev. 2019 03; 98:208-220.